Subependymal giant cell astrocytoma risk factors: Difference between revisions
Created page with "__NOTOC__ {{Subependymal giant cell astrocytoma}} {{CMG}}{{AE}}{{SR}} ==Reference== {{reflist|2}} Category:Disease Category:Types of cancer Category:Rare disease..." |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Subependymal giant cell astrocytoma}} | {{Subependymal giant cell astrocytoma}} | ||
{{CMG}}{{AE}}{{SR}} | |||
{{ | ==Overview== | ||
The most potent risk factor in the development of subependymal giant cell astrocytoma is [[tuberous sclerosis]].<ref name="pmid24138953">{{cite journal| author=Roth J, Roach ES, Bartels U, Jóźwiak S, Koenig MK, Weiner HL et al.| title=Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. | journal=Pediatr Neurol | year= 2013 | volume= 49 | issue= 6 | pages= 439-44 | pmid=24138953 | doi=10.1016/j.pediatrneurol.2013.08.017 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24138953 }} </ref> | |||
==Risk Factors== | |||
The most potent risk factor in the development of subependymal giant cell astrocytoma is [[tuberous sclerosis]].<ref name="pmid24138953">{{cite journal| author=Roth J, Roach ES, Bartels U, Jóźwiak S, Koenig MK, Weiner HL et al.| title=Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. | journal=Pediatr Neurol | year= 2013 | volume= 49 | issue= 6 | pages= 439-44 | pmid=24138953 | doi=10.1016/j.pediatrneurol.2013.08.017 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24138953 }} </ref> | |||
==Reference== | ==Reference== | ||
Revision as of 22:42, 3 November 2015
|
Subependymal giant cell astrocytoma Microchapters |
|
Differentiating Subependymal Giant Cell Astrocytoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Subependymal giant cell astrocytoma risk factors On the Web |
|
American Roentgen Ray Society Images of Subependymal giant cell astrocytoma risk factors |
|
Subependymal giant cell astrocytoma risk factors in the news |
|
Risk calculators and risk factors for Subependymal giant cell astrocytoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
The most potent risk factor in the development of subependymal giant cell astrocytoma is tuberous sclerosis.[1]
Risk Factors
The most potent risk factor in the development of subependymal giant cell astrocytoma is tuberous sclerosis.[1]
Reference
- ↑ 1.0 1.1 Roth J, Roach ES, Bartels U, Jóźwiak S, Koenig MK, Weiner HL; et al. (2013). "Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012". Pediatr Neurol. 49 (6): 439–44. doi:10.1016/j.pediatrneurol.2013.08.017. PMID 24138953.